ARCHIVES

Two Papers Evaluate CyberKnife Survival Rates and Tolerability

This article is from The Cancer Letter archive.

Vol. 36 No. 11 | November 29, 2013

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Task Force Must Take More Active Role In RFP Development, New Chairman Insists

November 14, 1975

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

Tissue of Origin Test Consistent With Diagnosis In Blinded Validation Study

January 28, 2011

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

CCOP Q&A, List Of Research Bases

September 10, 1982

Diet, Nutrition Committee To Rate Suggested Projects

January 9, 1976